Coherus Oncology, Inc.CHRSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank31
3Y CAGR+11.8%
5Y CAGR-30.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+11.8%/yr
vs -3.2%/yr prior
5Y CAGR
-30.3%/yr
Recent acceleration
Acceleration
+15.0pp
Accelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $88.88M | -29.5% |
| 2024 | $125.99M | +22.4% |
| 2023 | $102.89M | +61.9% |
| 2022 | $63.55M | -84.8% |
| 2021 | $417.19M | -22.9% |
| 2020 | $541.16M | +204.6% |
| 2019 | $177.67M | +145.5% |
| 2018 | $72.36M | -43.0% |
| 2017 | $126.91M | +1.6% |
| 2016 | $124.95M | - |